| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
144,960,000 |
| Market
Cap: |
1.77(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$12.75 - $29.77 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teladoc Health is a provider of virtual healthcare services. Co. provides a portfolio of services and solutions covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions including diabetes, hypertension, cancer and congestive heart failure. Co.'s consumer brands, which include Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, deliver access to advice and resolution to an array of healthcare needs. In its behavioral health business, including its BetterHelp brand, Co. serves individuals in the direct-to-consumer market and through business partnerships with other brands.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
205,748 |
278,151 |
369,866 |
493,207 |
| Total Sell Value |
$2,960,072 |
$4,454,156 |
$6,845,960 |
$10,218,420 |
| Total People Sold |
12 |
13 |
14 |
14 |
| Total Sell Transactions |
23 |
43 |
78 |
119 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Murthy Mala |
CHIEF FINANCIAL OFFICER |
• – – |
2022-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,968 |
31,348 |
|
- |
|
| Trencher Daniel |
SVP CORPORATE STRATEGY |
• – – |
2022-06-17 |
4 |
AS |
$29.12 |
$29,120 |
D/D |
(1,000) |
28,408 |
|
-7% |
|
| Geshuri Arnnon |
CHIEF PEOPLE OFFICER |
• – – |
2022-05-26 |
4 |
S |
$31.86 |
$92,012 |
D/D |
(2,888) |
80,280 |
|
20% |
|
| Daniel Karen L |
|
– • – |
2022-05-19 |
4 |
AS |
$31.18 |
$12,784 |
D/D |
(410) |
43,470 |
|
-20% |
|
| Mckinley Thomas |
|
– • – |
2022-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
7,517 |
|
- |
|
| Daniel Karen L |
|
– • – |
2022-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
43,880 |
|
- |
|
| Snow David B Jr |
|
– • – |
2022-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
50,019 |
|
- |
|
| Jacobson Catherine |
|
– • – |
2022-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
3,106 |
|
- |
|
| Bischoff Christopher |
|
– • – |
2022-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
7,195 |
|
- |
|
| Smith Mark Douglas |
|
– • – |
2022-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
819 |
4,355 |
|
- |
|
| Raman-Tangella Vidya |
CHIEF MEDICAL OFFICER |
• – – |
2022-04-25 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
17 |
|
- |
|
| Vandervoort Adam C |
Chief Legal Officer, Secretary |
• – – |
2022-03-07 |
4 |
S |
$66.74 |
$258,873 |
D/D |
(3,879) |
11,983 |
|
36% |
|
| Trencher Daniel |
SVP Corporate Strategy |
• – – |
2022-03-07 |
4 |
S |
$66.74 |
$109,582 |
D/D |
(1,642) |
29,408 |
|
36% |
|
| Turitz Andrew |
SVP - Business Development |
• – – |
2022-03-07 |
4 |
S |
$66.74 |
$89,027 |
D/D |
(1,334) |
14,794 |
|
36% |
|
| Verstraete Stephany |
Chief Marketing Officer |
• – – |
2022-03-07 |
4 |
S |
$66.74 |
$251,865 |
D/D |
(3,774) |
31,828 |
|
36% |
|
| Vandervoort Adam C |
Chief Legal Officer, Secretary |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,945 |
15,862 |
|
- |
|
| Trencher Daniel |
SVP Corporate Strategy |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,541 |
31,050 |
|
- |
|
| Turitz Andrew |
SVP - Business Development |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,541 |
16,128 |
|
- |
|
| Verstraete Stephany |
Chief Marketing Officer |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,512 |
35,602 |
|
- |
|
| Gorevic Jason N |
Chief Executive Officer |
• • – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,590 |
516,464 |
|
- |
|
| Trencher Daniel |
SVP CORPORATE STRATEGY |
• – – |
2022-03-03 |
4 |
S |
$70.24 |
$126,219 |
D/D |
(1,797) |
26,509 |
|
42% |
|
| Murthy Mala |
CHIEF FINANCIAL OFFICER |
• – – |
2022-03-03 |
4 |
S |
$70.24 |
$471,795 |
D/D |
(6,717) |
23,380 |
|
42% |
|
| Verstraete Stephany |
CHIEF MARKETING OFFICER |
• – – |
2022-03-03 |
4 |
S |
$70.24 |
$200,743 |
D/D |
(2,858) |
27,090 |
|
42% |
|
| Turitz Andrew |
SVP - BUSINESS DEVELOPMENT |
• – – |
2022-03-03 |
4 |
S |
$70.24 |
$123,199 |
D/D |
(1,754) |
11,587 |
|
42% |
|
| Vandervoort Adam C |
CHIEF LEGAL OFFICER, SECRETARY |
• – – |
2022-03-03 |
4 |
S |
$70.24 |
$246,750 |
D/D |
(3,513) |
7,917 |
|
42% |
|
956 Records found
|
|
Page 9 of 39 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.04 (0.33%) 
